Location First: Targeting Acute Myeloid Leukemia Within Its Niche

Despite extensive research and development of new treatments, acute myeloid leukemia (AML)-backbone therapy has remained essentially unchanged over the last decades and is frequently associated with poor outcomes. Eradicating the leukemic stem cells (LSCs) is the ultimate challenge in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Pievani, Alice, Biondi, Marta, Tomasoni, Chiara, Biondi, Andrea, Serafini, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290711/
https://www.ncbi.nlm.nih.gov/pubmed/32443460
http://dx.doi.org/10.3390/jcm9051513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290711/
https://www.ncbi.nlm.nih.gov/pubmed/32443460
http://dx.doi.org/10.3390/jcm9051513

Ejemplares similares